The monitoring of the accumulation of protoporphyrin IX in Walker tumours by subcutaneous administration of δ-aminolevulinic acid

Journal of Experimental Therapeutics and Oncology

Volumn 4, Issue 3, 2004, Pages 247-251

  Calin, Mihaela Antonina ^a   Gruia, Maria Iuliana ^b   Herascu, Nicoleta ^a   Coman, Toma ^c  

^a NATIONAL INSTITUTE OF RESEARCH AND DEVELOPMENT FOR OPTOELECTRONICS INOE 2000   (Romania)

^b Institutul Oncologic Prof Dr Alexandru Trestioreanu Bucuresti   (Romania)

^c SPIRU HARET UNIVERSITY   (Romania)

Author keywords

Fluorescence imaging; Laser; Photodynamic therapy; Photosensitizer

Indexed keywords

AMINOLEVULINIC ACID; PROTOPORPHYRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ACCUMULATION; DRUG DISTRIBUTION; FLUORESCENCE; IMAGE ANALYSIS; LASER; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RAT; SKIN CANCER; WALKER CARCINOMA;

EID: 9344222244     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Dougherty T J, Gomer C J, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q. Photodynamic Therapy. Journal of the National Cancer Institute 90(12): 889-905, 1998.
2. Dougherty T.J. Photodynamic Therapy. J Photochem Photobiol 58: 895-900, 1993.
3. Rhodes LE, Tsoudakas MM, Anderson RR, Kollias N. Iontophoretic delivery of ALA provides a quantitative model for ALA pharmaceutics and PpIX phototoxicy in human skin. J Invest Dermatol 108(1): 87-91, 1997.
4. De Bruijn, HS, Van der Veen N, Robinson DJ, Star WM. Improvement of systemic 5-aminolevulinic acid photodynamic therapy in-vivo using light fractionation with a 75-minute interval. Cancer Res 59: 901-904, 1999.
5. Stenzi A, Eder I, Kostron H, Klocker H, Bartsch G. Electromotive diffusion (emd) and photodynamic therapy with δ-aminolevulinic acid (δ-ALA) for superficial bladder cancer. J Photochem Photobiol B 36: 233-236, 1996.
6. Kloek J, Beijersbergen van Henegouwen GMJ. Prodrugs of 5-aminolevulinic acid for photodynamic therapy. Photochem Photobiol 64(6): 994-1000, 1996.
7. Harth Y, Hirshowitz B, Kaplan B. Modified topical photodynamic therapy of superficial skin tumors, utilizing aminolevulinic acid, penetration enhancers, red light, and hyperthermia. Dermatol Surg 24(7): 723-726, 1998.
8. Curnow A, Mcllroy BW, Postle-Hacon MJ, Porter JB, MacRobert AJ, Bown SG. Enhancement of 5-aminolevulinic acid induced photodynamic therapy using hydroxypyridione iron chelating agents. Br J Cancer 78(10): 1278-1282, 1998.
9. Ma L-W, Moam J, Peng Q, Iani V. Production of protoporfyrin IX induced by 5-aminolevulinic acid in transplanted human colon adenocarcinoma of nude mice can be increased by ultrasound. Int J Cancer 78: 464-469, 1998.
10. Anderson-Engels S, Wilson B C. In vivo fluorescence in clinical oncology: fundamental and practical issue. J Cell Pharmacol 3: 48-61, 1992.
11. Tope W D, Rose E V, Kollias N, Martin A, Gillies R, Andreson R R. Protoporphyrin IX fluorescence induced in basal cell carcinoma by oral delta-aminolevulinic acid. Photochem Photobiol 67(2): 249-255, 1998.